Inspire Medical Systems, Inc. Lessee, Operating Lease, Discount Rate
Inspire Medical Systems, Inc. (INSP) had Lessee, Operating Lease, Discount Rate of 4.90% as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2026-02-13
- 2025-12-31: Lessee, Operating Lease, Discount Rate 4.90%.
- 2025-09-30: Lessee, Operating Lease, Discount Rate 4.90%.
- 2025-06-30: Lessee, Operating Lease, Discount Rate 4.90%.
- 2025-03-31: Lessee, Operating Lease, Discount Rate 4.90%.
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2025-12-31 | 4.90% 10-K · filed 2026-02-13 |
| 2025-09-30 | 4.90% 10-Q · filed 2025-11-03 |
| 2025-06-30 | 4.90% 10-Q · filed 2025-08-04 |
| 2025-03-31 | 4.90% 10-Q · filed 2025-05-05 |
| 2024-12-31 | 4.90% 10-K · filed 2025-02-10 |
| 2024-09-30 | 4.90% 10-Q · filed 2024-11-04 |
| 2024-06-30 | 4.90% 10-Q · filed 2024-08-06 |
| 2024-03-31 | 4.90% 10-Q · filed 2024-05-07 |
| 2023-09-30 | 4.90% 10-Q · filed 2023-11-07 |
| 2023-06-30 | 4.90% 10-Q · filed 2023-08-01 |
| 2023-03-31 | 5.30% 10-Q · filed 2023-05-02 |
| 2022-09-30 | 5.30% 10-Q · filed 2022-11-01 |
| 2022-06-30 | 5.30% 10-Q · filed 2022-08-02 |
| 2022-03-31 | 5.30% 10-Q · filed 2022-05-03 |
| 2021-09-30 | 5.20% 10-Q · filed 2021-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |